PIB TrackerLight-driven nanobots aimed at breast cancer
Researchers built a multifunctional nanorobot steered by near-infrared light, designed to deliver drugs into tumours with control that conventional chemotherapy and passive nanomedicine lack.
What happened
- Researchers developed a light-driven multifunctional nanobot for targeted breast cancer therapy.
- Conventional chemotherapy causes side effects, drug resistance and healthy-tissue damage.
- Existing nanomedicines rely on passive tumour accumulation with poor spatial control.
- Most light-powered nanorobots need UV or visible light, which penetrates tissue poorly.
- Stimulus-responsive nanorobots use near-infrared light, magnetic fields, pH or enzymes for precise targeting.
For Prelims
- Nanorobot: a nanoscale device that can be actively steered to deliver therapy, unlike passive nanoparticles.
- Why near-infrared: NIR light penetrates tissue deeper than UV or visible light with less damage.
- Stimulus-responsive control: external cues (NIR light, magnetic fields) or internal cues (pH, enzymes).
- The problem addressed: chemotherapy's non-specific distribution, poor tumour penetration and lack of control after administration.
- Precision medicine: therapy targeted to the site and biology of disease, minimising systemic toxicity.
- Context: breast cancer is among the leading causes of cancer mortality in women worldwide.
For UPSC: A frontier-science item. Use it for nanotechnology in medicine, precision and targeted drug delivery, India's biomedical research capability, and the translation gap between laboratory innovation and clinical use.
What it is NOT: This is laboratory-stage research on a delivery platform — not an approved treatment, and clinical trials and regulatory approval lie ahead.
For Mains
Syllabus: GS3.13 · GS2.13 · Linkage L1
Anchor
Chemotherapy floods the body; a nanobot aims to visit only the tumour.
Substantiation (data)
A light-driven multifunctional nanobot using near-infrared control, addressing the poor tissue penetration and spatial control of passive nanomedicine and UV-driven nanorobots.
Exemplification
Near-infrared light penetrates tissue far deeper than visible light with less damage, which is what makes steering a device inside the body feasible.
Problematisation
The distance from a working nanobot to an approved therapy is long — biocompatibility, manufacturing scale-up, trials and cost all intervene.
Way-forward
Support translational pathways from laboratory to clinic and build affordable manufacturing so precision oncology is not restricted to the wealthy.
Position
Precision medicine will matter for India only if it arrives at a price the public system can carry.
Deploys into: Biotechnology + health (GS3.13, GS2.13) · nanotechnology in medicine, targeted drug delivery, and the laboratory-to-clinic translation gap.
Ministry of Science & Technology · 2026-08-05 · PRID 2295121 · PIB source ↗